Copy Link Print Information

Brentuximab

(Synonyms: CAC-10)
3 Cited Publications
Customer Review

Based on 3 publication(s) in Google Scholar

Brentuximab (CAC-10) is a chimeric antibody targeting CD30. Brentuximab is conjugated with Monomethyl auristatin E (MMAE) (HY-15162) to form the antibody-drug conjugate Brentuximab vedotin (HY-P99107A). Brentuximab can be used for the research of cancer, such as lymphoma.

For research use only. We do not sell to patients.

  • Purity: 99.64%
  • CAS No.: 2088770-90-3
  • Molecular Weight:145.48 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Brentuximab
  • Experimental Validation Results for Brentuximab
  • Experimental Validation Results for Brentuximab
  • Brentuximab Chemical Structure
    Brentuximab Chemical Structure
CAS No.: 2088770-90-3
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Brentuximab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Brentuximab

More

All TNF Receptor Isoforms

More

Keywords

MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG1 kappa

  • 1/16

    Immobilized CD30/TNFRSF8 Protein, Human can bind Brentuximab. The EC50 for this effect is 6.007 ng/mL.

  • 1/16

    Flow cytometric analysis of 1X106 Jurkat cells label Brentuximab (HY-P99151, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Fluor 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1(E356D/M358L) kappa (HY-P990100, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • Brentuximab Chemical Structure
    1/16
  • Brentuximab
  • Human IgG1 kappa
  • Immobilized CD30/TNFRSF8 Protein, Human can bind Brentuximab. The EC50 for this effect is 6.007 ng/mL.
  • Flow cytometric analysis of 1X106 Jurkat cells label Brentuximab (HY-P99151, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Fluor 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1(E356D/M358L) kappa (HY-P990100, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).